Abstract: The invention is directed to chemical processes of preparing fractions form North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
Type:
Application
Filed:
July 16, 2008
Publication date:
November 20, 2008
Applicant:
fx Life Sciences International GmbH
Inventors:
Jacqueline J. Shan, Peter K.T. Pang, Buhan Huang, Lei Ling
Abstract: The invention is directed to chemical processes of preparing fractions form North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
Type:
Grant
Filed:
April 26, 2005
Date of Patent:
August 19, 2008
Assignee:
fX Life Sciences International GmbH
Inventors:
Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
Abstract: Hypericin has been shown to specifically inhibited T-type calcium channel activity. Hypericum extract containing hypericin also inhibited T-type calcium channel activity. Moreover, other chemicals in Hypericum extract showed a synergistic effect to hypericin. In view of this, hypericin or hypericin-containing Hypericum extract can be used as T-channel blockers. Hypericum extract, extract of other species of the Hypericum genus, extract of other plants containing hypericin, hypericin, hypericin derivatives, hypericin analogs, such as pseudohypericin, and other hypericum extract constituents can be used as therapeutics targeted at T-type calcium channels for treatment of diseases associated with T-channel abnormality. Methods for administering hypericin and hypericum extract are disclosed.
Type:
Grant
Filed:
January 11, 2000
Date of Patent:
March 27, 2007
Assignee:
FX Life Sciences International GmbH
Inventors:
Jacqueline J. Shan, Xi-Chen Wu, Peter K. T. Pang, Lei Ling
Abstract: The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
Type:
Grant
Filed:
October 23, 2003
Date of Patent:
March 6, 2007
Assignee:
fx Life Sciences International GmbH
Inventors:
Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling